TAK-653 vs Semax
Side-by-side comparison of TAK-653 and Semax: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
TAK-653
Semax
TAK-653
TAK-653 is a novel positive allosteric modulator (PAM) of AMPA-type glutamate receptors developed by Takeda Pharmaceuticals. It enhances glutamatergic neurotransmission without directly activating the receptor, offering…
Lowest listed price: $79.99 across 1 listing
Full TAK-653 profileSemax
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP, 813 Da molecular weight) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. The compound is derived…
Lowest listed price: $32.90 across 5 listings
Full Semax profileSide-by-side comparison
| Attribute | TAK-653 | Semax |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Phase II Clinical Trials | Approved in Russia; registered as a prescription intranasal solution |
| Mechanism of Action | TAK-653 acts as a positive allosteric modulator (PAM) of AMPA receptors, binding to a site distinct from the glutamate binding site. It increases the receptor's sensitivity to glutamate, improving excitatory postsynaptic currents (EPSCs) and promoting… | Primary Mechanism: Multi-Pathway Neurotrophic Activation Semax produces its effects through coordinated activation of multiple neurotrophic, neurotransmitter, and neuroprotective pathways. Unlike conventional nootropics that target a single system (modafinil… |
| Half-Life | 6-10 hours (estimated) | ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes) |
| Typical Dose Range | 0.1 mg - 6 mg | 100-900 mcg intranasal daily (0.1% solution: 2-3 drops per nostril 2-3x daily); 1% solution used for acute stroke in Russian clinical protocols |
| Dosing Frequency | Once daily | Intranasal 1–3 times daily |
| Administration | Oral | Intranasal |
| Side Effects | Headache, mild nausea, insomnia (if taken late in day), potential overstimulation at higher doses. Seizure risk at supratherapeutic doses due to glutamatergic mechanism. Mild anxiety or agitation reported in some users. | Overall Safety Profile Semax has an excellent safety profile across 20+ years of Russian clinical use. In acute stroke trials, cognitive studies, and pediatric applications, Semax has demonstrated consistent tolerability with minimal adverse event burden. This… |
| Molecular Weight | 282.27 | 813.9 Da |
| Common Vial Sizes | — | 5mg, 10mg |
Price tracking
Price History
5 data points- OF
- Half Nattys
- Ion Peptide
- BHG Labs
TAK-653: potential benefits
- Cognitive enhancement and improved learning
- Antidepressant effects (treatment-resistant depression)
- Enhanced synaptic plasticity and LTP
- Increased BDNF expression
- Improved working memory and executive function
- Potential neuroprotective properties
Semax: potential benefits
- Rapid BDNF/TrkB upregulation in the hippocampus, supporting synaptic plasticity and learning (PMID: 16996037)
- Neuroprotective, immunomodulatory gene-expression changes in focal cerebral ischemia (middle cerebral artery occlusion) models (PMID: 28255762)
- Cognitive enhancement including improved attention, working memory, and processing speed
- Dopaminergic modulation that may support motivation and executive function (preclinical data)
- Stroke recovery facilitation - accelerated functional recovery and improved Barthel Index in ischemic stroke patients; approved in Russia for ischemic stroke (PMID: 29798983)
- Anxiolytic and anti-asthenic effects reported in Russian clinical use, attributed to neurotrophic and monoaminergic modulation
- Non-addictive cognitive support without tolerance development or withdrawal at standard doses
Frequently asked
What's the difference between TAK-653 and Semax?
TAK-653 is a nootropics that tak-653 acts as a positive allosteric modulator (pam) of ampa receptors, binding to a site distinct from the glutamate binding site. it increases the receptor's sensitivity to…. Semax is a nootropics that primary mechanism: multi-pathway neurotrophic activation semax produces its effects through coordinated activation of multiple neurotrophic, neurotransmitter, and neuroprotective…. The two differ in mechanism, half-life (6-10 hours (estimated) vs ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes)), and typical dose range.
Which has the longer half-life, TAK-653 or Semax?
TAK-653 has a half-life of 6-10 hours (estimated). Semax has a half-life of ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, TAK-653 or Semax?
Lowest listed price on BodyHackGuide: TAK-653 from $79.99, Semax from $32.90. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack TAK-653 and Semax?
Few pairs of research compounds have been tested together in people, so for most pairs no trial shows whether combining them is safe or adds anything. Each compound's page lists its side effects and the interactions in our record, and the table on this page puts their side effects side by side.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy TAK-653 or Semax
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.